Matias Healthcare Pvt Ltd
Etizolam (0.25mg)
Zoltias MD 0.25 Tablet is a prescription medicine used to treat short-term anxiety and insomnia. It binds to specific receptor sites in the brain and calms the brain.
Tablet MD
Zoltias MD 0.25 Tablet may be taken with or without food. However, take it at the same time each day as this helps to maintain a consistent level of medicine in the body. Take this medicine in the dose and duration as advised by your doctor as it has a high potential of habit-forming. If you have missed any doses, take it as soon as you remember it and finish the full course of treatment even if you feel better. You should not stop this medication without talking to your doctor as it may cause nausea and anxiety.
Take this medicine in the dose and duration as advised by your doctor. Do not handle the tablets with wet hands. Put it in your mouth but do not swallow it. Zoltias MD 0.25 Tablet may be taken with or without food but it is better to take it at a fixed time.
Zoltias MD 0.25 Tablet is a benzodiazepine. It works by increasing the action of a chemical messenger (GABA) which suppresses the abnormal and excessive activity of the nerve cells in the brain.
Take it as per dose and duration suggested by the doctor. The addiction / habit-forming potential of this medicine is less as compared to other benzodiazepines. It may cause dizziness. Do not drive or do anything that requires mental focus until you know how this medicine affects you. Avoid consuming alcohol as it may increase dizziness and drowsiness. Do not take this medicine if you have a history of drug addiction or drug abuse.
Yes, there is a report indicating the potential for abuse of Zoltias MD 0.25 Tablet. Therefore, it should be used with caution in patients at increased risk for substance abuse or misuse.
Compared to other benzodiazepines, Zoltias MD 0.25 Tablet generally exhibits lower sedative effects, a reduced potential for dependence, and a lower likelihood of developing tolerance. However, long-term use may lead to decreased medication effectiveness and increased risks of dependence and addiction.
Sudden discontinuation of Zoltias MD 0.25 Tablet can trigger withdrawal symptoms, including anxiety, insomnia, headache, dizziness, ringing in the ears (tinnitus), eating disorders (anorexia), vomiting, nausea, tremor, weakness, excessive sweating (perspiration), and irritability. In some cases, individuals may experience heightened sensitivity to light and sound, palpitations, fast heart rate, and postural hypotension (drop in blood pressure upon standing). Severe or rare instances of abrupt withdrawal can lead to seizures, mental disorders (psychosis), agitation, confusion, and hallucinations.
Oral doses of Zoltias MD 0.25 Tablet typically begin demonstrating effect within 30-60 minutes, peaking at 3-4 hours. However, the medication remains active for a period ranging from 6-8 hours, with higher doses potentially prolonging its effects.
Like other benzodiazepines, it causes muscle relaxation, but its primary use is for anxiety management.
While it may induce sleepiness similar to other benzodiazepines, Zoltias MD 0.25 Tablet primarily targets anxiety disorders. It increases total sleep duration and reduces the proportion of rapid eye movement (REM) sleep, a period characterized by rapid eye movements. However, it has no effect on sleep latency (the time required to fall asleep after waking).
No, Zoltias MD 0.25 Tablet is not considered an antidepressant. It is primarily prescribed for the treatment of generalized anxiety disorder with associated depressive symptoms but may affect individual mood.